Bio-Rad Laboratories (BIO-B) Non-Current Assets (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Non-Current Assets data on file, last reported at $6.8 billion in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $6.8 billion, up 350.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.8 billion (up 1248.01% YoY), and the FY2025 annual result was $7.7 billion, up 21.1% from the prior year.
• Non-Current Assets retreated to $6.8 billion in Q1 2026 per BIO-B's latest filing, from $7.7 billion in the prior quarter.
• Over five years, Non-Current Assets peaked at $11.1 billion in Q1 2022 and troughed at -$3.2 billion in Q4 2022.
• A 5-year average of $4.4 billion and a median of $6.9 billion in 2025 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2024 and 2026: Non-Current Assets tumbled 134.92% in 2024, then soared 350.98% in 2026.
• A 5-year view of Non-Current Assets shows it stood at -$3.2 billion in 2022, then grew by 3.46% to -$3.0 billion in 2023, then surged by 307.8% to $6.3 billion in 2024, then advanced by 21.1% to $7.7 billion in 2025, then decreased by 10.72% to $6.8 billion in 2026.
• Business Quant data shows BIO-B's Non-Current Assets at $6.8 billion in Q1 2026, $7.7 billion in Q4 2025, and $6.9 billion in Q3 2025.